Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress RFIL Q1 2026 Earnings Strong EPS Surprise Drives Share Gains Despite Limited Revenue Disclosure KT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Pulmatrix Q2 2025 Earnings Loss Per Share Widens Amidst No Revenue Disclosure GIPR Q1 2026 Earnings NarrowerThanExpected Loss Fails to Avert Stock Decline ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation